CHDS Seminar with Bart Ferket: The Promise of Risk Stratification for Cardiovascular Prevention in Diabetes
February 27th @ 1:00 pm - 2:00 pm
Abstract: For individuals with diabetes, calcium scoring is a promising approach for targeting primary prevention efforts for cardiovascular disease. We develop a microsimulation model based on Multi-Ethnic Study of Atherosclerosis (MESA) data, and subsequently compare costs and effectiveness of strategies utilizing clinical risk stratification alone versus combining it with calcium scoring. In addition to providing insights related to the usefulness of these approaches, this work has several implications for developing decision models of chronic disease based on individual participant data analysis.
Bio: Bart Ferket (MD 2005, University of Amsterdam; PhD 2013, Erasmus University) is an Associate Professor in the Department of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai, NYC. Ferket’s research focuses on applying quantitative methods to evaluate health and economic outcomes for various chronic, non-communicable diseases. His research particularly concerns: 1) prevention of cardiovascular disease, 2) value of surgical procedures, and 3) utility of novel biomarkers and imaging tests.